Trending Articles

Positive data in hand, TG Therapeutics readies MS drug for FDA review

Bio Pharma Dive

If approved, TG's drug would join Roche's fast-selling Ocrevus and Novartis' newer entrant Kesimpta as one of a newer class of multiple sclerosis therapies

Drugs 212

Pharma Tuesday Stuff

World of DTC Marketing

QUICK READ: Here are some recent stories that you should all be aware of. Last month I hit 80,000 readers when accounting for email, social media, and direct traffic. I love the industry, and although I want to see some changes, I know there are many good people trying every day to make it happen.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

US calls for pause in J&J coronavirus vaccine rollout after rare blood clotting cases

Bio Pharma Dive

The FDA and CDC recommended halting vaccinations while they investigate six cases of unusual blood clots in women given the company's shot

UK Vaccine Taskforce head lifts lid on Novavax deal

Pharma Phorum

The UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its COVID-19 jab there, according to the head of the country’s Vaccines Taskforce. .

Single metasurface for simultaneous detection of SAM and OAM


Credit: by Yinghui Guo, Shicong Zhang, Mingbo Pu, Qiong He, Jinjin Jin, Mingfeng Xu, Yaxin Zhang, Ping Gao, Xiangang Luo With inherent orthogonality, both SAMs and OAMs of light have been utilized to expand the dimensions of optical communications and signal processing, wherein unambiguous SAM and OAM identification is one of the significant topics.


Inovio’s DNA Vaccine Generates Robust Responses Against COVID-19 Variants in Study


Shares of Inovio are climbing in early trading this morning after the company announced its DNA vaccine candidate for COVID-19 induced a robust T-cell response against multiple variants of the SARS-CoV-2 virus

DNA 106

The danger of COVID conspiracy theorists

World of DTC Marketing

QUICK READ: At times, the public health response to coronavirus (COVID-19) has been scary, characterized by antimask behavior, antivaccine beliefs, conspiracy theories around the development of the vaccine, and a general belief that even COVID numbers are false.

More Trending

Fearsome tyrannosaurs were social animals, study suggests


The report, based on research at a unique fossil site in Utah, provides new evidence that tyrannosaurs were social carnivores and not solitary hunters as popularly envisioned. Credit: U.S. Bureau of Land Management FAYETTEVILLE, Ark.

Moderna to take mRNA flu and HIV vaccines into Phase 1 trials this year

BioPharma Reporter

Moderna will take mRNA flu and HIV vaccines into Phase 1 trials this year, as well as beginning a pivotal Phase 3 study for its cytomegalovirus (CMV) vaccine candidate. Bio Developments

FDA faces backlash after seeking more data on an experimental ALS therapy

Bio Pharma Dive

The ALS Association demanded the FDA "move with the urgency" other agencies have in reviewing a drug from Amylyx Pharmaceuticals

Drugs 238

The internet enables misinformation on COVID

World of DTC Marketing

QUICK READ: Some deaths will occur during the COVID-19 vaccination rollout, but these deaths would have happened for other reasons and are unrelated to the vaccine.

RNA 169

Thermo Fisher Scientific snaps up PPD in $17.4b acquisition deal

Outsourcing Pharma

The science service and technologies firm plans to bring the CRO under its Laboratory Products and Services Segment umbrella after the deal is completed. Markets & Regulations

Astronauts’ mental health risks tested in the Antarctic


No bounce back for declines in positive emotion Credit: University of Houston Astronauts who spend extended time in space face stressors such as isolation, confinement, lack of privacy, altered light-dark cycles, monotony and separation from family.

NICE says yes to Novartis’ multiple sclerosis therapy Kesimpta

Pharma Phorum

Novartis has secured backing from NICE for its relapsing multiple sclerosis (RMS) therapy Kesimpta in the UK, just two weeks after the drug was approved by the national drugs regulator. .

Sales 74

A startup raises $336M to make a better antibody drug for COVID-19

Bio Pharma Dive

Adagio Therapeutics, a well-financed spinout of antibody developer Adimab, could challenge Regeneron and Eli Lilly if its drug candidate proves protective in clinical tests

Reaching HCPs online

World of DTC Marketing

QUICK READ: Recent research from Zoom Rx saying that digital interactions with HCPs are myopic and don’t apply to the heavily segmented HCP audience. The future of reaching HCPS is both on and off-line depending on the product, health condition, and specialty.

SHINE, Phoenix merger focused on advancing fusion technology

BioTech 365

SHINE, Phoenix merger focused on advancing fusion technology SHINE, Phoenix merger focused on advancing fusion technology JANESVILLE & FITCHBURG, Wis.–(BUSINESS


Surpassing the lower limit on computing energy consumption


Topological materials beat Boltzmann’s tyranny Credit: Errol Hunt (FLEET) New FLEET research confirms the potential for topological materials to substantially reduce the energy consumed by computing.

Can you use montelukast for allergies? [ANSWERED]


Montelukast, a prescription-only medication, is mainly used as add on therapy in the treatment of asthma , usually in patients who cannot control their condition with an inhaled steroid and who cannot control their asthma with ‘short acting’ inhaler such as Ventolin (Salbutamol).

CDC panel delays decision on J&J vaccine, extending pause over rare side effect

Bio Pharma Dive

Advisers to the agency agreed to wait for more data before recommending new guidance, but aim to reconvene quickly to decide on whether vaccinations with J&J's should be resumed, and for whom

And so pharma profiteers again

World of DTC Marketing

QUICK READ: Pfizer has already announced a price increase to the EU for their Covid Vaccine. With a CEO who earns more than $20 million annually and the potential for billions in profit Pfizer is reminding us that Wall Street is once again their primary customer.

Sales 165

Northwell Health Teams With Pear Therapeutics to Provide New Treatment for Patients With Substance Use Disorders

BioTech 365

Northwell Health Teams With Pear Therapeutics to Provide New Treatment for Patients With Substance Use Disorders Northwell Health Teams With Pear Therapeutics to Provide New Treatment for Patients With Substance Use Disorders NEW HYDE PARK, N.Y.–(BUSINESS


Chaperone protein imbalance promotes toxic tau buildup in the aging brain


Early-Career Chemistry Researchers Tell How Reaxys Supports Their Innovative Work

Pharma R&D Today

The Reaxys PhD Prize is a global competition that recognizes accomplished young chemists for their innovative research. The only requirements to participate are that one must be in the process of completing a PhD, or recently have completed one – and it can be in any discipline of chemistry.

Moderna watches for 'waning immunity' as new data show durable vaccine protection

Bio Pharma Dive

Updated study results show Moderna's coronavirus vaccine was strongly protective against COVID-19 through six months. But executives outlined contingency plans in case those effects fade

Pharma agency challenges and opportunities

World of DTC Marketing

QUICK READ: According to Setup 30% of Brand marketers say they’re likely/somewhat likely to switch Agencies in the next 6 months. While the consolidation of agencies may be a priority for some pharma companies a good digital agency can add a lot of value.

Chan Family Makes Generous Donation to the KGI School of Pharmacy and Health Sciences

BioTech 365

Chan Family Makes Generous Donation to the KGI School of Pharmacy and Health Sciences Chan Family Makes Generous Donation to the KGI School of Pharmacy and Health Sciences CLAREMONT, Calif.–(BUSINESS

Gold digger: Neural networks at the nexus of data science and electron microscopy


Enhertu accepted via cancer drugs fund for HER2-positive breast cancer

Pharma Times

Decision is based on results from the Phase II DESTINY-Breast01 trial

Vertex bets another $900M on CRISPR treatment for blood diseases

Bio Pharma Dive

Vertex and CRISPR Therapeutics are tweaking their partnership so that the larger biotech will cover 60% of the costs — and receive 60% of the future profits — related to a gene editing therapy for sickle cell disease and beta thalassemia

Monkey-Human Hybrid Research Offers Promise, but Sparks Ethical Debate


According to the researchers, who published their findings online in Cell, certain experiments can't be conducted in humans, making nearly human hybrids a possible solution to this investigational barrier

2021 Susan G. Komen MBC Impact Series to Provide Year-Long Resource for MBC Community

BioTech 365

2021 Susan G. Komen MBC Impact Series to Provide Year-Long Resource for MBC Community 2021 Susan G.


Clinical trial assesses stem cells’ ability to prevent major cause of preemie deaths


Credit: AlphaMed Press Durham, NC – A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants.

Phico Therapeutics gains £13.1m grant to advance antibacterial therapy

Pharma Times

SASPject PT3.9 is designed for the treatment of hospital infections caused by Pseudomonas aeruginosa


The next 2 months in biotech and pharma will be busy. Here's what to watch.

Bio Pharma Dive

New developments could come soon for two coronavirus vaccines while, a bit further off, the fate of Biogen's Alzheimer's drug hangs in the balance. Important data are expected, too, for Vertex and Sarepta

COVID-19 Infection After Vaccine is Rare But Possible, CDC Says


The U.S. CDC said up to 5,800 people who have been fully vaccinated against coronavirus disease 2019 (COVID-19) have been infected by the novel coronavirus following vaccination

Adesis Achieves ISO 9001:2015 Certification

BioTech 365

Adesis Achieves ISO 9001:2015 Certification Adesis Achieves ISO 9001:2015 Certification NEW CASTLE, Del.–(BUSINESS –(BUSINESS WIRE)–$OLED #OLED—Adesis, Inc.,